- 1The Second School of Medicine, Guangxi Medical University, Nanning, China
- 2Child Healthcare Department, The Second People’s Hospital of Beihai, Beihai, China
- 3Center for Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China
- 4The Guangxi Health Commission Key Laboratory of Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, China
A Correction on
By Zhan L, Gui C, Wei W, Liu J and Gui B (2023). Front. Pediatr. 11:1199609. doi: 10.3389/fped.2023.1199609
Incorrect funding
In the published article, there was an error in the Funding statement. [The current funding statement: “This work was supported in part by the National Natural Science Foundation of China (82001531 and 81860272 to BG), Guangxi Major Research Programme (AB22035013 to BG), Guangxi Natural Science Foundation (2023GXNSFBA026124 to CG, 2018GXNSFAA281067 to BG), Initial Scientific Research Fund for Advanced Talents from The Second Affiliated Hospital of Guangxi Medical University (2019112 to BG), Special Scientific Research Fund of Guangxi Ten-Hundred-Thousand Talents Project (2021186 to BG), and the Science Foundation for Young Scholars of Guangxi Medical University (GXMUYSF202115 to CG), Beihai Science and Technology Plan Project (2019D06 to LZ).”
Upon reviewing the final version of the article, we have identified an error in the order of the funds listed. The current order of the funds does not accurately reflect the primary sources of support for the research. Specifically, the Guangxi Major Research Programme (AB22035013 to BG) should be listed first, followed by the National Natural Science Foundation of China (82001531 and 81860272 to BG), and so on. The correct order of the funds are crucial for proper attribution and compliance with the funding agencies' requirements.]. The correct Funding statement appears below.
Funding
[This work was supported in part by the Guangxi Major Research Programme (AB22035013 to BG), National Natural Science Foundation of China (82001531 and 81860272 to BG), Guangxi Natural Science Foundation (2023GXNSFBA026124 to CG, 2018GXNSFAA281067 to BG), Initial Scientific Research Fund for Advanced Talents from The Second Affiliated Hospital of Guangxi Medical University (2019112 to BG), Special Scientific Research Fund of Guangxi Ten-Hundred-Thousand Talents Project (2021186 to BG), and the Science Foundation for Young Scholars of Guangxi Medical University (GXMUYSF202115 to CG), Beihai Science and Technology Plan Project (2019D06 to LZ)]
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: third-generation sequencing, nanopore sequencing, single-molecule real-time sequencing, thalassemia, screening, diagnosis
Citation: Zhan L, Gui C, Wei W, Liu J and Gui B (2025) Correction: Third generation sequencing transforms the way of the screening and diagnosis of thalassemia: a mini-review. Front. Pediatr. 13:1637415. doi: 10.3389/fped.2025.1637415
Received: 19 June 2025; Accepted: 19 June 2025;
Published: 2 July 2025.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright: © 2025 Zhan, Gui, Wei, Liu and Gui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Baoheng Gui, YmFvaGVuZ2d1aUB5ZWFoLm5ldA==